Accomplished Senior Research Scientist with over ten years of experience across academia and industry, including impactful contributions at AstraZeneca. Expert in assay development, advanced screening technologies, and oligonucleotide safety evaluation, with a proven track record in driving successful drug discovery projects from conception to execution. Recognized for mentoring and developing junior scientists, fostering collaborative, high-performing teams, and championing innovation through strategic problem-solving and cross-functional leadership.
Sreenivasan K, et al. "Attenuated epigenetic suppression of muscle stem cell necroptosis..." Cell Reports. 2020.
Sreenivasan K, et al. "CHD4 ensures stem cell lineage fidelity during skeletal muscle regeneration." Stem Cell Reports. 2021.
Gómez-del Arco P, Sreenivasan K, et al. "The chromatin remodeling complex Chd4/NuRD controls striated muscle identity..." Cell Metabolism. 2016.
Full publication list: Google Scholar: Krishnamoorthy Sreenivasan
PhD and Post-doctoral representative, Max Planck Institute for Heart and Lung Research, 2013-2022
Organizing yearly soft skill workshops and retreats for PhD and postdoctoral students.
Acting as a liaison between students and faculty to solve any pertaining conflicts of interest, establishing a post-doctoral association within the institute, and providing a platform for career building
Organizing career development events in close collaboration with the Max Planck Academy and the Max Planck Society, PostdocNet.
Best Poster award at the German Stem Cell Network (GSCN) conference (2016)
Boehringer Ingelheim Fond Travel Grant (05/2008 - 06/2008)
University Rank holder both during Bachelors and Masters (2002 - 2007)
Indian Institute of Technology, Madras (IIT-M) summer internship (05/2006 - 07/2006)